{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:49:31Z","timestamp":1793087371569,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijantimicag.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T13:33:14Z","timestamp":1552656794000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates"],"prefix":"10.1016","volume":"54","author":[{"given":"Elizabeth G.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6501-492X","authenticated-orcid":false,"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0001","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archinte.167.8.834","article-title":"Age- and sex-associated trends in bloodstream infection","volume":"167","author":"Uslan","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1469-0691.2003.00599.x","article-title":"Source of infection and other factors associated with case fatality in community-acquired bacteremia\u2014a Danish population-based cohort study from 1992 to 1997","volume":"9","author":"Pedersen","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/oxfordjournals.aje.a114206","article-title":"Bacteremia in Charleston County, South Carolina","volume":"123","author":"Filice","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkp162","article-title":"Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998\u20132007","volume":"64","author":"Al-Hasan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0005","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/AAC.00119-14","article-title":"Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0006","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.02728-15","article-title":"Prediction of fluoroquinolone resistance in Gram-negative bacteria causing bloodstream infections","volume":"60","author":"Dan","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/ice.2016.292","article-title":"Clinical risk score for prediction of extended-spectrum \u03b2-lactamase producing Enterobacteriaceae in bloodstream isolates","volume":"38","author":"Augustine","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0008","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","article-title":"Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome","volume":"63","author":"Ortega","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0009","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/AAC.02239-13","article-title":"Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010","volume":"58","author":"Suda","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1017\/ice.2018.26","article-title":"Outpatient antibiotic prescription trends in the United States: a national cohort study","volume":"39","author":"Durkin","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0011","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/MLR.0000000000000440","article-title":"Antibiotic use in cold and flu season and prescribing quality: a retrospective cohort study","volume":"53","author":"Alsan","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0012","doi-asserted-by":"crossref","first-page":"e8109","DOI":"10.1073\/pnas.1809354115","article-title":"Benefits of antibiotics burden in low income countries","volume":"115","author":"Abat","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0013","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.inf.0000151092.85759.6d","article-title":"Penicillin susceptibility of pneumococcal isolates causing acute otitis media in children: seasonal variation","volume":"24","author":"Hoberman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0015","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/528995","article-title":"Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?","volume":"197","author":"Dagan","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/INF.0000000000000620","article-title":"Seasonal variation in penicillin susceptibility and invasive pneumococcal disease","volume":"34","author":"Iroh Tam","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0017","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0018","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0019","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1469-0691.2009.02877.x","article-title":"Seasonal variation in Escherichia coli bloodstream infection: a population-based study","volume":"15","author":"Al-Hasan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0021","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1469-0691.2009.02866.x","article-title":"Seasonal peaks in Escherichia coli infections: possible explanations and implications","volume":"15","author":"Freeman","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.cmi.2015.06.023","article-title":"Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset","volume":"21","author":"Deeny","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0950268814000880","article-title":"National patterns of Escherichia coli O157 infections, USA, 1996\u20132011","volume":"143","author":"Sodha","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0024","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2015.05.015","article-title":"Urinary Escherichia coli antimicrobial susceptibility profiles and their relationship with community antibiotic use in Tasmania","volume":"46","author":"Meumann","year":"2015","journal-title":"Australia. Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eimc.2017.10.013","article-title":"Trend and seasonality of community-acquired Escherichia coli antimicrobial resistance and its dynamic relationship with antimicrobial use assessed by ARIMA models","volume":"36","author":"Asencio Egea","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0026","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/cis509","article-title":"Seasonality and temporal correlation between community antibiotic use and resistance in the United States","volume":"55","author":"Sun","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0027","doi-asserted-by":"crossref","first-page":"e02313","DOI":"10.1128\/AAC.02313-16","article-title":"Application of fluoroquinolone resistance score in management of complicated urinary tract infections","volume":"61","author":"Shah","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00732-17","article-title":"Epidemic emergence in the United States of Escherichia coli sequence type 131-H30 (ST131-H30), 2000 to 2009","volume":"61","author":"Johnson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0029","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/432940","article-title":"Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy","volume":"41","author":"Lautenbach","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cmi.2015.05.013","article-title":"Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization","volume":"21","author":"Brigmon","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0031","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0032","unstructured":"US Centers for Disease Control and Prevention. Antibiotic use in the United States, 2017: progress and opportunities. Atlanta, GA: CDC. https:\/\/www.cdc.gov\/antibiotic-use\/stewardship-report\/outpatient.html[accessed 15 July 2018]."},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0033","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","article-title":"Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis","volume":"2","author":"Collignon","year":"2018","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0034","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0035","series-title":"Outpatient antibiotic prescriptions\u2014United States","year":"2015"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0036","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(18)30056-2","article-title":"The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial","volume":"18","author":"van Duijn","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.03.010_bib0037","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhin.2018.06.015","article-title":"Season, weather and predictors of healthcare-associated Gram-negative bloodstream infections: a case-only study","volume":"101","author":"Rodrigues","year":"2019","journal-title":"J Hosp Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T17:11:40Z","timestamp":1560273100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919300639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0924857919300639"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}